Home > > > > > Report Detail

Global Ophthalmic Drug Market Forecast 2019-2027

Publisher Name :
Date: 10-Jun-2019
No. of pages: 124

KEY FINDINGS

The global ophthalmic drugs market is anticipated to grow at a CAGR of 4.31% between 2019 and 2027 to generate revenue of $38,473 million by 2027. An existing predominance and increase in the number of eye disorders with a growing geriatric population all over the world are the primary drivers responsible for market growth. With increasing awareness of ophthalmic drugs among the consumers and patients is anticipated to proliferate the market growth.

MARKET INSIGHTS

The technological advancements, rise in eye disorders, growth in geriatric population, cataract surgeries and upsurge in healthcare expenditure are dominant drivers for the growth of ophthalmic drugs market. Vast scope for ophthalmic drugs market is created with the predominance of eye-related disorders and ailments. One major cause of half-blindness and decreased vision is the cataract, which has the highest percentage accountable for worldwide visual impairment. Cataract surgery is risk-free and secure kind of surgery; the safety has led to an increase in the cataract surgeries. The boost in Health expenditure has boosted consumer spending, thus indirectly driving the ophthalmic drugs market.

REGIONAL INSIGHTS

North America accounts for the largest market share in the global ophthalmic drugs market. Europe accounts for the second largest market share in the global ophthalmic drugs market. Asia-Pacific is estimated to expand at the highest CAGR during the forecast period. Asia-Pacific is also anticipated to emerge as a leading destination for drug development during the forecast years. The rise in the aged population and the existence of dominant market players in the regions are driving the regional markets.

COMPETITIVE INSIGHTS

The predominant ophthalmic drugs companies in the global market are Bayer, Allergan Inc., Sun Pharmaceuticals Industries, Ltd., Valeant, GlaxoSmithKline, Apollo Endosurgery, Regeneron, Senju Pharmaceutical Co., Ltd., Abbott Laboratories, Merck & Co., Novartis AG, Roche Holding AG, Pfizer Inc., Cipla Pharmaceuticals, Eyegate Pharmaceuticals, and Johnson and Johnson.

Global Ophthalmic Drug Market Forecast 2019-2027

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top-Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Retinal Disorders Are The Highest Revenue Generating Indication
3.2.2. Prescription Drugs Are The Fastest Growing Ophthalmic Drugs Type
3.2.3. Hospital Pharmacies Are The Majorly Used Distribution Channel
3.2.4. Liquid Ophthalmic Drug Forms Are The Widely Used Dosage Form
3.2.5. Anti-Allergy Therapeutic Class Is Anticipated To Grow At A Significant Rate During The Forecast Period
3.2.6. Small Molecule Technology Is Used For The Treatment Of Eye Diseases
4. Market Determinants
4.1. Market Definition And Scope
4.2. Market Drivers
4.2.1. Increasing Geriatric Population
4.2.2. Technological Advancement
4.2.3. Rising Prevalence Of Eye Disorders
4.2.4. Increased Healthcare Expenditure
4.3. Market Restraints
4.3.1. Renowned Drugs Going Off-Patent
4.3.2. Delay In Drug Approvals
4.4. Market Opportunities
4.4.1. Increase In Disorder Symptom And Improved Diagnosis Leading To Higher Treatment Rates
4.4.2. Growing Opportunities In Developing Economies
4.5. Market Challenges
4.5.1. Side Effects Related To The Ophthalmic Drugs
5. Market By Indication
5.1. Dry Eye
5.2. Glaucoma
5.3. Infection/Inflammation/Allergy
5.4. Retinal Disorders
5.4.1. Wet Age-Related Macular Degeneration
5.4.2. Dry Age-Related Macular Degeneration
5.4.3. Diabetic Retinopathy
5.4.4. Other Retinal Disorders
5.5. Other Indication
6. Market By Type
6.1. Prescription Drugs
6.2. Over-The-Counter Drugs
7. Market By Distribution Channel
7.1. Hospital Pharmacies
7.2. Drug Stores
7.3. Online Pharmacies
7.4. Other Distribution Channel
8. Market By Dosage Form
8.1. Liquid Ophthalmic Drug Forms
8.2. Solid Ophthalmic Drug Forms
8.3. Semisolid Ophthalmic Drug Forms
8.4. Multicompartment Drug Delivery Systems
8.5. Other Ophthalmic Drug Forms
9. Market By Therapeutic Class
9.1. Anti-Glaucoma
9.2. Anti-Infective
9.3. Anti-Inflammatory
9.4. Anti-Allergy
10. Market By Technology
10.1. Biologics
10.2. Cell Therapy
10.3. Gene Therapy
10.4. Drug Delivery
10.5. Small Molecule
10.6. Other Technology
11. Key Analytics
11.1. Porter's Five Forces Analysis
11.1.1. Bargaining Power Of Buyers
11.1.2. Bargaining Power Of Supplier
11.1.3. Threats Of New Entrants
11.1.4. Threats Of Substitutes
11.1.5. Competitive Rivalry
11.2. Value Chain Analysis
11.2.1. Research And Development
11.2.2. Manufacturing
11.2.3. Marketing And Distribution
11.3. Regulatory Framework
11.4. Opportunity Matrix
12. Geographical Analysis
12.1. North America
12.1.1. The United States
12.1.2. Canada
12.2. Europe
12.2.1. Germany
12.2.2. The United Kingdom
12.2.3. France
12.2.4. Italy
12.2.5. Spain
12.2.6. Rest Of Europe
12.3. Asia Pacific
12.3.1. China
12.3.2. India
12.3.3. Japan
12.3.4. South Korea
12.3.5. Australia
12.3.6. Rest Of Asia Pacific
12.4. Rest Of World
12.4.1. Middle East & Africa
12.4.2. Latin America
13. Company Profiles
13.1. Abbott Laboratories
13.2. Allergan Inc.
13.3. Johnson And Johnson
13.4. Bayer
13.5. Valeant
13.6. Regeneron
13.7. Pfizer Inc.
13.8. Merck & Co.
13.9. Novartis Ag
13.10. Glaxosmithkline
13.11. Eyegate Pharmaceuticals
13.12. Apollo Endosurgery
13.13. Roche Holding Ag
13.14. Cipla Pharmaceuticals
13.15. Senju Pharmaceutical Co., Ltd.
13.16. Sun Pharmaceuticals Industries, Ltd.

List of Tables

Table 1 Global Ophthalmic Drug Market Revenue By Region 2019-2027 ($ Million)
Table 2 Common Causes Of Loss Of Vision In The Elderly
Table 3 Eye Drugs Gone Off-Patent
Table 4 Global Ophthalmic Drugs Market By Indication 2019-2027 ($ Million)
Table 5 Global Dry Eye Market By Region 2019-2027 ($ Million)
Table 6 Global Ophthalmic Drugs Market By Dry Eye 2019-2027 ($ Million)
Table 7 Global Glaucoma Market By Region 2019-2027 ($ Million)
Table 8 Global Infection/Inflammation/Allergy Market By Region 2019-2027 ($ Million)
Table 9 Global Retinal Disorders Market By Region 2019-2027 ($ Million)
Table 10 Global Wet Age-Related Macular Degeneration Market By Region 2019-2027 ($ Million)
Table 11 Global Dry Age-Related Macular Degeneration Market By Region 2019-2027 ($ Million)
Table 12 Global Diabetic Retinopathy Market By Region 2019-2027 ($ Million)
Table 13 Global Other Retinal Disorders Market By Region 2019-2027 ($ Million)
Table 14 Global Other Indication Market By Region 2019-2027 ($ Million)
Table 15 Global Ophthalmic Drugs Market By Type 2019-2027 ($ Million)
Table 16 Global Prescription Drugs Market By Region 2019-2027 ($ Million)
Table 17 Global Over-The-Counter Drugs Market By Region 2019-2027 ($ Million)
Table 18 Global Ophthalmic Drugs Market By Distribution Channel 2019-2027 ($ Million)
Table 19 Global Hospital Pharmacies Market By Region 2019-2027 ($ Million)
Table 20 Global Drug Stores Market By Region 2019-2027 ($ Million)
Table 21 Global Online Pharmacies Market By Region 2019-2027 ($ Million)
Table 22 Global Other Distribution Channel Market By Region 2019-2027 ($ Million)
Table 23 Global Ophthalmic Drugs Market By Dosage Form 2019-2027 ($ Million)
Table 24 Global Liquid Ophthalmic Drug Forms Pharmacies Market By Region 2019-2027 ($ Million)
Table 25 Global Solid Ophthalmic Drug Forms Market By Region 2019-2027 ($ Million)
Table 26 Global Semisolid Ophthalmic Drug Forms Market By Region 2019-2027 ($ Million)
Table 27 Global Multicompartment Drug Delivery Systems Market By Region 2019-2027 ($ Million)
Table 28 Global Other Ophthalmic Drug Forms Market By Region 2019-2027 ($ Million)
Table 29 Global Ophthalmic Drugs Market By Therapeutic Class 2019-2027 ($ Million)
Table 30 Global Anti-Glaucoma Market By Region 2019-2027 ($ Million)
Table 31 Global Anti-Infective Market By Region 2019-2027 ($ Million)
Table 32 Global Anti-Inflammatory Market By Region 2019-2027 ($ Million)
Table 33 Global Anti-Allergy Market By Region 2019-2027 ($ Million)
Table 34 Global Ophthalmic Drugs Market By Technology 2019-2027 ($ Million)
Table 35 Global Biologics Market By Region 2019-2027 ($ Million)
Table 36 Global Cell Therapy Market By Region 2019-2027 ($ Million)
Table 37 Global Gene Therapy Market By Region 2019-2027 ($ Million)
Table 38 Global Drug Delivery Market By Region 2019-2027 ($ Million)
Table 39 Global Small Molecule Market By Region 2019-2027 ($ Million)
Table 40 Global Other Technology Market By Region 2019-2027 ($ Million)
Table 41 Global Ophthalmic Drugs Market By Region 2019-2027 ($ Million)
Table 42 North America Ophthalmic Drugs Market By Country 2019-2027 ($ Million)
Table 43 Europe Ophthalmic Drugs Market By Country 2019-2027 ($ Million)
Table 44 Asia Pacific Ophthalmic Drugs Market By Country 2019-2027 ($ Million)

List of Figures

Figure 1 The Population Of People Aged 65 And Over Will Double In The Next 25 Years (In Millions)
Figure 2 Projections For The Proportion Of Geriatric (60+) Population In 2015, 2030 & 2050
Figure 3 Worldwide Prevalence Of Presbyopia 2015, 2020 & 2050 (Billion)
Figure 4 Prevalence Of Glaucoma At Global Level In 2013, 2020 & 2040 (Million)
Figure 5 Healthcare Expenditure Cataract Surgeries On The Rise
Figure 6 Global Ophthalmic Drugs Market By Glaucoma2019-2027 ($ Million)
Figure 7 Global Ophthalmic Drugs Market By Infection/ Inflammation/ Allergy 2019-2027 ($ Million)
Figure 8 Global Ophthalmic Drugs Market By Retinal Disorders 2019-2027 ($ Million)
Figure 9 Global Retinal Disorders Market By Wet Age-Related Macular Degeneration 2019-2027 ($ Million)
Figure 10 Global Retinal Disorders Market By Dry Age-Related Macular Degeneration 2019-2027 ($ Million)
Figure 11 Global Retinal Disorders Market By Diabetic Retinopathy 2019-2027 ($ Million)
Figure 12 Global Retinal Disorders Market By Other Retinal Disorders 2019-2027 ($ Million)
Figure 13 Global Ophthalmic Drugs Market By Other Indication 2019-2027 ($ Million)
Figure 14 Global Ophthalmic Drugs Market By Prescription Drugs 2019-2027 ($ Million)
Figure 15 Global Ophthalmic Drugs Market By Over-The-Counter Drugs 2019-2027 ($ Million)
Figure 16 Global Ophthalmic Drugs Market By Hospital Pharmacies 2019-2027 ($ Million)
Figure 17 Global Ophthalmic Drugs Market By Drug Stores 2019-2027 ($ Million)
Figure 18 Global Ophthalmic Drugs Market By Online Pharmacies 2019-2027 ($ Million)
Figure 19 Global Ophthalmic Drugs Market By Other Distribution Channel 2019-2027 ($ Million)
Figure 20 Global Ophthalmic Drugs Market By Liquid Ophthalmic Drug Forms 2019-2027 ($ Million)
Figure 21 Global Ophthalmic Drugs Market By Solid Ophthalmic Drug Forms 2019-2027 ($ Million)
Figure 22 Global Ophthalmic Drugs Market By Semisolid Ophthalmic Drug Forms 2019-2027 ($ Million)
Figure 23 Global Ophthalmic Drugs Market By Multicompartment Drug Delivery Systems 2019-2027 ($ Million)
Figure 24 Global Ophthalmic Drugs Market By Other Ophthalmic Drug Forms 2019-2027 ($ Million)
Figure 25 Global Ophthalmic Drugs Market By Anti-Glaucoma 2019-2027 ($ Million)
Figure 26 Global Ophthalmic Drugs Market By Anti-Infective 2019-2027 ($ Million)
Figure 27 Global Ophthalmic Drugs Market By Anti-Inflammatory 2019-2027 ($ Million)
Figure 28 Global Ophthalmic Drugs Market By Anti-Allergy 2019-2027 ($ Million)
Figure 29 Global Ophthalmic Drugs Market By Biologics 2019-2027 ($ Million)
Figure 30 Global Ophthalmic Drugs Market By Cell Therapy 2019-2027 ($ Million)
Figure 31 Global Ophthalmic Drugs Market By Gene Therapy 2019-2027 ($ Million)
Figure 32 Global Ophthalmic Drugs Market By Drug Delivery 2019-2027 ($ Million)
Figure 33 Global Ophthalmic Drugs Market By Small Molecule 2019-2027 ($ Million)
Figure 34 Global Ophthalmic Drugs Market By Other Technology 2019-2027 ($ Million)
Figure 35 The United States Population Ages 65 And Older, 1960 To 2060 (Million)
Figure 36 The United States Ophthalmic Drugs Market 2019-2027 ($ Million)
Figure 37 Canada Ophthalmic Drugs Market 2019-2027 ($ Million)
Figure 38 Prevalence Rate Of Retinal Disorders In Canada, 2016
Figure 39 Europe Ophthalmic Drugs Market 2019-2027 ($ Million)
Figure 40 Development Of The European Population Aged 65 And Over, 2010, 2025 & 2050 (In Million)
Figure 41 Germany Ophthalmic Drugs Market 2019-2027 ($ Million)
Figure 42 The United Kingdom Ophthalmic Drugs Market 2019-2027 ($ Million)
Figure 43 Projected Number Of People Living With Sight Loss In The Uk (In Million)
Figure 44 Population Aged 65 And Above In France (% Of Total)
Figure 45 France Ophthalmic Drugs Market 2019-2027 ($ Million)
Figure 46 Italy Ophthalmic Drugs Market 2019-2027 ($ Million)
Figure 47 Spain Ophthalmic Drugs Market 2019-2027 ($ Million)
Figure 48 Rest Of Europe Ophthalmic Drugs Market 2019-2027 ($ Million)
Figure 49 Asia Pacific Ophthalmic Drugs Market 2019-2027 ($ Million)
Figure 50 China Ophthalmic Drugs Market 2019-2027 ($ Million)
Figure 51 India Ophthalmic Drugs Market 2019-2027 ($ Million)
Figure 52 Japan Ophthalmic Drugs Market 2019-2027 ($ Million)
Figure 53 South Korea Ophthalmic Drugs Market 2019-2027 ($ Million)
Figure 54 Number Of Years For Percentage, Aged 65 And Above In Total Population To Triple
Figure 55 Australia Ophthalmic Drugs Market 2019-2027 ($ Million)
Figure 56 Rest Of Asia Pacific Ophthalmic Drugs Market 2019-2027 ($ Million)
Figure 57 Middle East & Africa Ophthalmic Drugs Market 2019-2027 ($ Million)
Figure 58 Latin America Ophthalmic Drugs Market 2019-2027 ($ Million)
Figure 59 Aging Population In Colombia 1950-2050 (In Thousands)
  • Global Artificial Tears Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 91
    Artificial tears are lubricant eye drops used to treat The dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations. The global Artificial Tears market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 5240.1 million by 2030, witnessing a CAGR of 8.6% during The forecast period 2024-2030. The industry's leading producers are Aller......
  • Global Contact Lens Solution Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 96
    Contact lens solution is a kind of solution that is used to contact lens with The function of cleaning, disinfection, rinsing or preservation, it can also alleviate The eyeball discomfort which caused by wear The contact lens. Contact lens solution can direct contact eyeball, so it must be accord with industrial standard. The global Contact Lens Solution market was valued at US$ 4087.6 million in 2023 and is anticipated to reach US$ 5323.5 million by 2030, witnessing a CAGR of 3.8% ......
  • Global Latanoprost Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 82
    Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside The eye. Onset of effects is usually within four hours, and they last for up to a day. Latanoprost is used to treat high pressure inside The eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in The body (prostaglandin) and works by regulating The flow of fluid within The eye which results in lower pressure. Lowerin......
  • Global Contact Lens Solution Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Contact Lens Solution market: According to our latest research, the global Contact Lens Solution market looks promising in the next 5 years. As of 2022, the global Contact Lens Solution market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Contact ......
  • Global Dry Eye Syndrome Drugs Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The Dry Eye Syndrome Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive......
  • Global Eye Drops & Lubricants Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Eye Drops & Lubricants market size was valued at US$ 8841.8 million in 2023. With growing demand in downstream market, the Eye Drops & Lubricants is forecast to a readjusted size of US$ 9780.8 million by 2030 with a CAGR of 1.5% during review period. The research report highlights the growth potential of the global Eye Drops & Lubricants market. Eye Drops & Lubricants are expected to show stable growth in the future market. H......
  • Global Conjunctivitis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98
    According to our LPI (LP Information) latest study, the global Conjunctivitis market size was valued at US$ 3482.7 million in 2023. With growing demand in downstream market, the Conjunctivitis is forecast to a readjusted size of US$ 3908 million by 2030 with a CAGR of 1.7% during review period. The research report highlights the growth potential of the global Conjunctivitis market. Conjunctivitis are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Contact Lens Solution Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118
    According to our LPI (LP Information) latest study, the global Contact Lens Solution market size was valued at US$ 3998.7 million in 2023. With growing demand in downstream market, the Contact Lens Solution is forecast to a readjusted size of US$ 5241.5 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Contact Lens Solution market. Contact Lens Solution are expected to show stable growth in the future market. Howev......
  • Global Latanoprost Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Latanoprost market size was valued at US$ 1344.2 million in 2023. With growing demand in downstream market, the Latanoprost is forecast to a readjusted size of US$ 1574.2 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Latanoprost market. Latanoprost are expected to show stable growth in the future market. However, product differentiation, reducing co......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs